In fact, the FDA-approved indication is to reduce visceral abdominal fat in HIV-associated lipodystrophy
Growth Hormone Secretagogues Ipamorelin, Tesamorelin, CJC-1295 & more Tissue & Recovery Peptides BPC-157, TB-500, BPC/TB Blends Metabolic Research Tirzepatide, Retatrutide, Semaglutide Melanocortin Peptides Melanotan I, Melanotan II Longevity & Mitochondrial MOTS-C, GHK-Cu, NAD+ compounds Research Supplies Bacteriostatic water, reconstitution supplies Quality Assurance Process From synthesis to delivery: compounds pass through a rigorous verification process

Weeks 1 to 2: Markedly increased appetite within minutes of each injection Improved sleep quality and deeper rest Some users report more vivid dreams Weeks 3 to 4: Faster recovery from exercise and reduced delayed-onset muscle soreness Mild water retention and increased skin fullness Subtle improvement in energy levels Weeks 6 to 8: Body composition changes become more visible, gradual reduction in subcutaneous fat and improved muscle fullness Skin quality improvements, including increased hydration Joint comfort improvements from enhanced collagen synthesis Weeks 10 to 12: More significant body composition shifts with consistent training and nutrition Strength and recovery gains become more pronounced Hair and nail growth improvements are sometimes reported Weeks 12 to 16+: Cumulative benefits reach their peak Appetite stimulation typically remains consistent and does not diminish GH response may begin to plateau

The only authorised manufacturers of Mounjaro and Wegovy are Eli Lilly and Novo Nordisk respectively
These agents may potentially increase the risk of recurrence or worsen prognosis